These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29075755)

  • 21. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated Speech Rate Measurement in Dysarthria.
    Martens H; Dekens T; Van Nuffelen G; Latacz L; Verhelst W; De Bodt M
    J Speech Lang Hear Res; 2015 Jun; 58(3):698-712. PubMed ID: 25860856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward phonetic intelligibility testing in dysarthria.
    Kent RD; Weismer G; Kent JF; Rosenbek JC
    J Speech Hear Disord; 1989 Nov; 54(4):482-99. PubMed ID: 2811329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consonant articulation acoustics and intelligibility in Swedish speakers with Parkinson's disease: a pilot study.
    Johansson IL; Samuelsson C; Müller N
    Clin Linguist Phon; 2023 Sep; 37(9):845-865. PubMed ID: 35833475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Speaking Rate on Variability of Second Formant Frequency Transitions in Dysarthria.
    van Brenk F; Lowit A; Tjaden K
    Folia Phoniatr Logop; 2024; 76(3):295-308. PubMed ID: 37769645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing speech intelligibility of pathological speech in sentences and word lists: The contribution of phoneme-level measures.
    Xue W; van Hout R; Cucchiarini C; Strik H
    J Commun Disord; 2023; 102():106301. PubMed ID: 36709701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of SPEAK OUT! & LOUD Crowd on Functional Speech Measures in Parkinson's Disease.
    Sullivan L; Martin E; Allison KM
    Am J Speech Lang Pathol; 2024 Jul; 33(4):1930-1951. PubMed ID: 38838243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contextual effects in the measurement of hearing-impaired speakers' intelligibility.
    Sitler RW; Schiavetti N; Metz DE
    J Speech Hear Res; 1983 Mar; 26(1):30-5. PubMed ID: 6865378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
    Carl M; Levy ES; Icht M
    Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of speaking task on intelligibility in Parkinson's disease.
    Tjaden K; Wilding G
    Clin Linguist Phon; 2011 Feb; 25(2):155-68. PubMed ID: 20887216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.
    Beijer LJ; Rietveld AC; Ruiter MB; Geurts AC
    Clin Linguist Phon; 2014 Dec; 28(12):927-50. PubMed ID: 25025268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Objective Intelligibility Assessment by Automated Segmental and Suprasegmental Listening Error Analysis.
    Jiao Y; LaCross A; Berisha V; Liss J
    J Speech Lang Hear Res; 2019 Sep; 62(9):3359-3366. PubMed ID: 31525112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acoustic and Perceptual Consequences of Speech Cues for Children With Dysarthria.
    Levy ES; Chang YM; Ancelle JA; McAuliffe MJ
    J Speech Lang Hear Res; 2017 Jun; 60(6S):1766-1779. PubMed ID: 28655046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acoustic and perceptual consequences of clear and loud speech.
    Tjaden K; Richards E; Kuo C; Wilding G; Sussman J
    Folia Phoniatr Logop; 2013; 65(4):214-20. PubMed ID: 24504015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speech-Language Pathologists' Use of Intelligibility Measures in Adults With Dysarthria.
    Gurevich N; Scamihorn SL
    Am J Speech Lang Pathol; 2017 Aug; 26(3):873-892. PubMed ID: 28772293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.